BDSX

0.882

4.22% -0.0389

Dopo l'orario di chiusura: .88 -0.002 -0.23%

Biodesix Inc (BDSX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$0.9209

Aprire:

$0.92

Volume 24 ore:

241.86K

Relative Volume:

0.51

Capitalizzazione di mercato:

$128.30M

Reddito:

$49.09M

Utile/perdita netta:

$-52.15M

Rapporto P/E:

-1.3569

EPS:

-0.65

Flusso di cassa netto:

$-45.93M

1 W Prestazione:

-10.46%

1M Prestazione:

-17.57%

6M Prestazione:

-50.45%

1 anno Prestazione:

-39.59%

Intervallo 1D:

$0.875

$0.9686

Intervallo di 1 settimana:

$0.875

$1.02

Portata 52W:

$0.8568

$2.04

Biodesix Inc Stock (BDSX) Company Profile

Nome

Biodesix Inc

Settore

Healthcare (1169)

Industria

Diagnostics & Research (60)

Telefono

303-417-0500

Indirizzo

919 WEST DILLON ROAD, LOUISVILLE

Dipendente

217

Cinguettio

Prossima data di guadagno

2024-11-27

Ultimi documenti SEC

BDSX's Discussions on Twitter

Confronta BDSX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BDSX Biodesix Inc	0.882	128.30M	49.09M	-52.15M	-45.93M	-0.65
TMO Thermo Fisher Scientific Inc	532.55	203.70B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	210.23	151.18B	23.88B	3.90B	5.30B	5.28
A Agilent Technologies Inc	135.37	38.62B	6.51B	1.29B	1.37B	4.42
IDXX Idexx Laboratories Inc	452.77	37.07B	3.90B	887.87M	808.08M	10.67
IQV Iqvia Holdings Inc	191.04	33.64B	15.41B	1.37B	2.11B	7.50

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-09-16	Iniziato	Scotiabank	Sector Outperform
2024-07-26	Iniziato	Craig Hallum	Buy
2024-05-13	Iniziato	TD Cowen	Buy
2024-05-03	Iniziato	Lake Street	Buy
2021-11-17	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-11-23	Iniziato	BTIG Research	Buy
2020-11-23	Iniziato	Canaccord Genuity	Buy
2020-11-23	Iniziato	Morgan Stanley	Overweight
2020-11-23	Iniziato	William Blair	Outperform

Mostra tutto

Biodesix Inc Borsa (BDSX) Ultime notizie

Feb 18, 2025

Biodesix, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - Nasdaq

Feb 18, 2025

Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - GlobeNewswire

Feb 18, 2025

Feb 17, 2025

Insider Selling: Biodesix, Inc. (NASDAQ:BDSX) CEO Sells 83,660 Shares of Stock - MarketBeat

Feb 17, 2025

Biodesix, Inc. (NASDAQ:BDSX) Insider Gary Anthony Pestano Sells 16,748 Shares - MarketBeat

Feb 17, 2025

Biodesix, Inc. (NASDAQ:BDSX) CFO Robin Harper Cowie Sells 24,664 Shares - MarketBeat

Feb 17, 2025

Feb 16, 2025

Stephens Inc. AR Makes New $303,000 Investment in Biodesix, Inc. (NASDAQ:BDSX) - Defense World

Feb 16, 2025

Feb 15, 2025

Biodesix chief accounting officer Chris Vazquez sells $3,354 in stock By Investing.com - Investing.com Australia

Feb 12, 2025

Biodesix CEO Scott Hutton sells shares worth $77,318 By Investing.com - Investing.com Australia

Feb 12, 2025

Biodesix chief commercial officer sells shares worth $16,198 By Investing.com - Investing.com Australia

Feb 12, 2025

Biodesix CFO sells $22,794 in stock By Investing.com - Investing.com Australia

Feb 12, 2025

BIODESIX Executives Sell Shares to Cover Taxes - TradingView

Feb 12, 2025

Feb 06, 2025